Inhibitory effects of SHP2 blocker NSC-87877 on inflammatory pain and its underlying mechanisms

Chinese Pharmacological Bulletin

Volumn 26, Issue 9, 2010, Pages 1142-1145

  Yang, Hong Bin ^a   Yang, Xian ^a   Cao, Jing ^a   Li, Shuai ^a   Liu, Yan Ni ^a   Suo, Zhan Wei ^a   Zheng, Cheng Rong ^a   Cui, Hong Bin ^a   Guo, Zhong ^b   Hu, Xiao Dong ^a  

^a LANZHOU UNIVERSITY   (China)

^b Med Coll Northwest Minorities U   (China)

Author keywords

Inflammatory pain; NMDA receptor; NSC 87877; Phosphatase; SHP2; Spinal dorsal horn; Synaptic trafficking

Indexed keywords

FREUND ADJUVANT; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2A; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B; NSC 87877; PROTEIN TYROSINE PHOSPHATASE INHIBITOR; PROTEIN TYROSINE PHOSPHATASE SHP 2; UNCLASSIFIED DRUG;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; FOREFOOT; IMMUNOBLOTTING; MOUSE; NOCICEPTION; NONHUMAN; OUTCOME ASSESSMENT; PAIN THRESHOLD; PROTEIN EXPRESSION; SPINAL CORD DORSAL HORN; SYNAPTIC EFFICACY;

EID: 78651091564     PISSN: 10011978     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Gogas K R. Glutamate-based therapeutic approaches: NR2B receptor antagonists[J]. Curr Opin Pharmacol,2006,6:68-74.
2. Yang X, Yang H B, Xie Q J, et al. Peripheral inflammation increased the synaptic expression of NMDA receptors in spinal dorsal horn[J]. Pain,2009,144:162-9.
3. Pelkey K A, Askalan R, Paul S, et al. Tyrosine phosphatase STEP is a tonic brake on induction of long-term potentiation[J]. Neuron,2002,34:127-38.
4. Prybylowski K, Chang K, Sans N, et al. The synaptic localization of NR2B-containing NMDA receptors is controlled by interactions with PDZ proteins and AP-2[J]. Neuron,2005,47:845-57.
5. Neel B G, Gu H, Pao L. The Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling[J]. Trends Biochem Sci,2003,28:284-93.
6. Roskoski R Jr. Src kinase regulation by phosphorylation and dephosphorylation[J]. Biochem Biophys Res Commun,2005,331:1-14.
7. Si Y F, Zhu X C, Sun D S, et al. Role of SHP-2 in apoptosis of HEK293T cells induced by arsenic trioxide[J]. Chin Phamacol Bull,2009,25(8):1086-9.
8. Chen L, Sung S S, Yip M L, et al. Discovery of a novel shp2 protein tyrosine phosphatase inhibitor[J]. Mol Pharmacol,2006,70:562-70.
9. Ji X L, Yan L D, Zhou P L, et al. Antinociception of omega-conotoxin ω-SO3 in rat formalin test after acute or chronic intrathecal administration[J]. Chin Phamacol Bull,2010,26(4):62-8.
10. Hylden J L, Wilcox G L. Intrathecal morphine in mice: a new technique[J]. Eur J Pharmocol,1980,67:313-6.
11. Lau C G, Zukin R S. NMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders[J]. Nat Rev Neurosci,2007,8:413-26.
12. Le H T, Maksumova L, Wang J, Pallen C J. Reduced NMDA receptor tyrosine phosphorylation in PTPalpha-deficient mouse synaptosomes is accompanied by inhibition of four src family kinases and Pyk2: an upstream role for PTPalpha in NMDA receptor regulation[J]. J Neurochem,2006,98:1798-809.